IRIS
ROVIELLO, GIANDOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.034
EU - Europa 2.733
AS - Asia 1.378
SA - Sud America 215
AF - Africa 76
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.980
RU - Federazione Russa 686
GB - Regno Unito 622
CN - Cina 496
IE - Irlanda 403
SG - Singapore 374
UA - Ucraina 204
SE - Svezia 184
VN - Vietnam 183
BR - Brasile 180
IT - Italia 163
HK - Hong Kong 130
FR - Francia 127
DE - Germania 119
FI - Finlandia 69
KR - Corea 45
ES - Italia 43
IN - India 43
ZA - Sudafrica 42
CA - Canada 31
BE - Belgio 30
LU - Lussemburgo 21
AR - Argentina 17
IQ - Iraq 17
MX - Messico 17
BD - Bangladesh 12
NG - Nigeria 12
IR - Iran 10
JP - Giappone 9
CZ - Repubblica Ceca 8
TR - Turchia 8
CI - Costa d'Avorio 7
PL - Polonia 7
AT - Austria 6
ID - Indonesia 6
JO - Giordania 6
LT - Lituania 6
AU - Australia 5
CO - Colombia 5
KZ - Kazakistan 5
NL - Olanda 5
PH - Filippine 5
PK - Pakistan 5
VE - Venezuela 5
GR - Grecia 4
IL - Israele 4
NO - Norvegia 4
SA - Arabia Saudita 4
CL - Cile 3
MA - Marocco 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
HN - Honduras 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SV - El Salvador 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 8.444
Salva come PNG Salva come JPEG
Città #
Southend 544
Fairfield 521
Dallas 494
Dublin 400
Ashburn 280
Woodbridge 245
Moscow 217
Singapore 217
Ann Arbor 208
Chandler 194
Wilmington 179
Seattle 177
Jacksonville 176
Cambridge 175
Houston 174
Santa Clara 152
Hong Kong 124
Beijing 112
San Jose 105
New York 68
Princeton 65
Los Angeles 58
Siena 58
Ho Chi Minh City 57
Nanjing 56
Seoul 45
Munich 43
Johannesburg 39
Hanoi 37
Hefei 36
Málaga 35
The Dalles 34
Boardman 32
Lauterbourg 32
Brussels 29
San Mateo 29
Shenyang 28
Columbus 27
Helsinki 25
Council Bluffs 24
Shanghai 22
Dong Ket 20
London 20
Hebei 18
São Paulo 18
Nanchang 17
San Diego 17
Orem 16
Buffalo 14
Jiaxing 14
Roodt-sur-Syre 14
Chennai 13
Milan 13
Venezia 13
Abuja 12
Changsha 11
San Francisco 11
Toronto 11
Phoenix 10
Zhengzhou 10
Da Nang 9
Dearborn 9
Denver 9
Manchester 9
Stockholm 9
Boston 8
Ningbo 8
Norwalk 8
Tianjin 8
Tokyo 8
Abidjan 7
Atlanta 7
Frankfurt am Main 7
Guangzhou 7
Kunming 7
Lappeenranta 7
Montreal 7
Turku 7
Zanjan 7
Baghdad 6
Brno 6
Jinan 6
Mexico City 6
Poplar 6
Warsaw 6
Amman 5
Barnet 5
Belo Horizonte 5
Düsseldorf 5
Elk Grove Village 5
Nuremberg 5
Pisa 5
Taizhou 5
Viareggio 5
Andover 4
Brasília 4
Brooklyn 4
Colle di Val d'Elsa 4
Delhi 4
Dhaka 4
Totale 6.098
Salva come PNG Salva come JPEG
Nome #
C-Met targeting in advanced gastric cancer: An open challenge 327
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 306
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 298
Familial aggregation of gastric cancer with microsatellite instability** 282
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 269
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 268
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 265
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 258
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 257
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 255
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 255
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 242
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 242
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 240
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 238
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 220
Apatinib in metastatic gastric cancer: can paclitaxel make the difference? 217
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 214
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 213
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status 213
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 211
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 201
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients 186
Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification 180
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer 174
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 171
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 164
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 162
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 158
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 145
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 134
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 118
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 115
null 112
null 112
null 110
null 109
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 105
null 103
Surgical management of advanced gastric cancer: An evolving issue 99
null 98
null 98
null 96
null 96
null 88
Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer 76
null 39
Totale 8.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 0 0 0 0 100 67 54
2021/2022500 44 35 34 22 27 25 16 18 29 63 68 119
2022/2023740 41 44 106 92 77 146 28 55 81 39 15 16
2023/2024603 20 11 41 22 11 162 232 5 1 46 24 28
2024/20251.015 22 68 129 60 152 55 11 47 70 41 148 212
2025/20262.509 220 340 388 338 565 111 280 64 86 117 0 0
Totale 8.539